INSUBCONTINENT EXCLUSIVE:
Chandan Taparia of Motilal Oswal Securities has a buy call on Divi's Laboratories Ltd
with a target price of Rs 2200.0
The current price of Divi's Laboratories Ltd
Chandan Taparia recommended to keep a stoploss at Rs 2030
Divi's Laboratories Ltd., incorporated in the year 1990, is a Large Cap company (having a market cap of Rs 55407.27 Crore) operating in
key Products/Revenue Segments include Active Pharma Ingredients which contributed Rs 4727.84 Crore to Sales Value (96.88 % of Total Sales),
Export Incentives which contributed Rs 116.91 Crore to Sales Value (2.39 % of Total Sales), Scrap which contributed Rs 25.53 Crore to Sales
Value (0.52 % of Total Sales) and Contract Fees which contributed Rs 9.38 Crore to Sales Value (0.19 % of Total Sales)for the year ending
For the quarter ended 31-12-2019, the company has reported a Consolidated sales of Rs 1396.26 Crore, down -3.41 % from last quarter Sales
of Rs 1445.57 Crore and up 2.67 % from last year same quarter Sales of Rs 1359.96 Crore Company has reported net profit after tax of Rs
359.09 Crore in latest quarter
K Seshavataram, Mr.Kiran S Divi, Mr.Madhusudana Rao Divi, Mr.N V Ramana, Mr.R Ranga Rao, Ms.Nilima Motaparti, Prof.Sunaina Singh
Company has Price Waterhouse Chartered Accountants LLP as its auditors As on 31-12-2019, the company has a total of 265,468,580 shares